“Great scientific strides can be made by solving small but fundamental problems.”

Suzanne Saffie-Siebert

Pharmaceutical Pipeline

We reformulate approved drug molecules with our patented ProSilic® bio-courier technology. This significantly reduces the risks and costs usually associated with new drug development and offers faster market approval via the FDA’s 505(b)(2) regulatory pathway.

Compound
Regulatory Pathway
Disease Area
Development Phase
SIS-008
OTC
Anti-acne
Late stage clinical
SIS-009
OTC
Anti-acne
Clinical
SIS-010
OTC
Anti-fungal in women’s health
Preclinical
SIS-1001
Rx
Keloid and hypertrophic scars
Pre-IND
SIS-1002
Rx
Actinic keratosis
Preclinical
SIS-2001
Rx
Psoriasis
Preclinical

Partnered Pipeline

We develop ProSilic® formulations for licensees in the pharmaceutical and animal health sectors.

Compound
Regulatory Pathway
Disease Area
Development Phase
SIS-3001 - Partnered
Rx
Autoimmune alopecia
Preclinical
VacSaf1 - Partnered
-
FMDV (foot and mouth disease virus)
Field trial ready

Consumer Pipeline

We develop and manufacture consumer skincare formulations for the Good Science Beauty™ brand owned by our U.S. subsidiary, GSB Laboratories.

Product
Ingredients
Development Phase
Launch Date
001-Pu Pure
Willow Bark + Amino Acids
Launch
Launched Q2 18
002-Re Renew
Good Silicon + Bentonite
Manufacture
Q3 18
003-Hy Hydrate
Hyaluronic Acid + Omega 3
Manufacture
Q3 18
004-Br Brighten
Glutathione + Melatonin
Manufacture
Q3 18
005-Fi Firm
Poria Cocos + Barley Extract
Formulation
Q4 18
006-WP Winter Protect
Vitamin D3 + Omega 3
Fomulation
2019
007-SP Sun Protect
Vitamin D3 + SPF
Fomulation
2019